Pressemeldinger

New clinical study shows important step in improving safety for patients and staff during cardiac interventions - 50% less X-ray dose

21-05-2013 17:25 Philips For the first time in cardiac interventional imaging, Philips’ new live image guidance technology AlluraClarity enables interventions to be performed with 50% less X-ray dose while maintaining equal image quality.

Philips Announces Completion of Enrollment in Therapeutic Hypothermia Clinical Study for Heart Attack Patients

06-05-2013 08:55 Philips CHILL-MI study to further evaluate the safety and effectiveness of the InnerCool RTx endovascular cooling system to reduce reperfusion injury in acute ST-elevation myocardial infarction patients

EU-funded program to develop first “cookbook” for coordinated care and telehealth deployment

29-04-2013 08:55 Philips Advancing Care Coordination and Telehealth Deployment program to explore processes for bringing care into the home for the chronically ill

22-04-2013 13:21 Philips Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL, Amsterdam, the Netherlands) has signed an agreement to join a research group to advance the development of ground-breaking image-guided treatment technology for cancer care

22-04-2013 11:26 Philips Philips operational results improve by 31% to EUR 421 million; net income at EUR 162 million

BIOGEN IDEC COMPLETES PURCHASE OF FULL RIGHTS AND CONTROL OF TYSABRI®

03-04-2013 11:30 Biogen Idec Norway AS

BIOGEN IDEC’S TECFIDERA™ (DIMETHYL FUMARATE) APPROVED IN US AS A FIRST-LINE ORAL TREATMENT FOR MULTIPLE SCLEROSIS

03-04-2013 11:24 Biogen Idec Norway AS Offers a Broad Spectrum of Patients with Relapsing Forms of MS an Effective and Convenient Treatment Option - - Reduces Relapses and Disability Progression - - Strengthens Biogen Idec’s Portfolio of Innovative Treatments for People Living with MS -

15-03-2013 08:55 Philips Philips vil kartlegge obstruktiv søvnapne – en forløper til diabetes og hjertesykdom

Tannkrem som skummer kan gi deg munnsår

25-02-2013 16:06 Midsona Norge AS Munnsold kan unngås ved bruk av tannkrem uten sulfat. SLS er et såpestoff som er svært vanlig å bruke i tannkrem. Stoffet, som er et sulfat, avgir skum og er av mange oppfattet som en vanlig egenskap ved tannkrem. SLS er imidlertid kjent som en av de viktigste årsakene til at man utvikler tilbakevennende munnsår. Norsk Tannpleierforening anbefaler bruk av tannkrem uten sulfat for å unngå munnskold

 Philips accelerates Green Innovation and reports revenue from Green Products reaching close to half of total sales

25-02-2013 12:41 Philips Today Royal Philips Electronics (NYSE:PHG, AEX:PHIA) reported Green Product sales of EUR 11.3 billion in 2012, marking 45% of total sales and moving the company significantly closer to its EcoVision sustainability performance targets of 2015.